Return On Assets of Monopar Therapeutics from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Monopar Therapeutics quarterly and annual Return On Assets in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Monopar Therapeutics Return On Assets for the quarter ending 30 Sep 2025 was -25%, a 72% increase year-over-year.
  • Monopar Therapeutics annual Return On Assets for 2024 was -76%, a 14% increase from 2023.
  • Monopar Therapeutics annual Return On Assets for 2023 was -88%, a 31% decline from 2022.
  • Monopar Therapeutics annual Return On Assets for 2022 was -67%, a 73% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Monopar Therapeutics Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -25% +63% +72% 01 Jul 2025 30 Sep 2025
Q2 2025 -39% +49% +56% 01 Apr 2025 30 Jun 2025
Q1 2025 -52% +35% +40% 01 Jan 2025 31 Mar 2025
Q4 2024 -76% +13% +14% 01 Oct 2024 31 Dec 2024
Q3 2024 -88% -1.5% -1.8% 01 Jul 2024 30 Sep 2024
Q2 2024 -89% -9.3% -12% 01 Apr 2024 30 Jun 2024
Q1 2024 -86% -12% -16% 01 Jan 2024 31 Mar 2024
Q4 2023 -88% -21% -31% 01 Oct 2023 31 Dec 2023
Q3 2023 -86% -27% -46% 01 Jul 2023 30 Sep 2023
Q2 2023 -80% -26% -50% 01 Apr 2023 30 Jun 2023
Q1 2023 -75% -29% -65% 01 Jan 2023 31 Mar 2023
Q4 2022 -67% -28% -73% 01 Oct 2022 31 Dec 2022
Q3 2022 -59% -21% -55% 01 Jul 2022 30 Sep 2022
Q2 2022 -53% -17% -47% 01 Apr 2022 30 Jun 2022
Q1 2022 -45% -6.7% -17% 01 Jan 2022 31 Mar 2022
Q4 2021 -39% +2.6% +6.2% 01 Oct 2021 31 Dec 2021
Q3 2021 -38% -0.43% -1.1% 01 Jul 2021 30 Sep 2021
Q2 2021 -36% +4.4% +11% 01 Apr 2021 30 Jun 2021
Q1 2021 -38% +4.2% +9.9% 01 Jan 2021 31 Mar 2021
Q4 2020 -42% +14% +25% 01 Oct 2020 31 Dec 2020
Q3 2020 -38% +26% +41% 01 Jul 2020 30 Sep 2020
Q2 2020 -41% +16% +28% 01 Apr 2020 30 Jun 2020
Q1 2020 -43% +4.6% +9.7% 01 Jan 2020 31 Mar 2020
Q4 2019 -56% -18% -50% 01 Oct 2019 31 Dec 2019
Q3 2019 -64% -32% -98% 01 Jul 2019 30 Sep 2019
Q2 2019 -56% 01 Apr 2019 30 Jun 2019
Q1 2019 -47% 01 Jan 2019 31 Mar 2019
Q4 2018 -37% 01 Oct 2018 31 Dec 2018
Q3 2018 -32% 01 Jul 2018 30 Sep 2018

Monopar Therapeutics Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -76% +13% +14% 01 Jan 2024 31 Dec 2024
2023 -88% -21% -31% 01 Jan 2023 31 Dec 2023
2022 -67% -28% -73% 01 Jan 2022 31 Dec 2022
2021 -39% +2.6% +6.2% 01 Jan 2021 31 Dec 2021
2020 -42% +14% +25% 01 Jan 2020 31 Dec 2020
2019 -56% -16% -41% 01 Jan 2019 31 Dec 2019
2018 -39% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.